play_arrow

keyboard_arrow_right

skip_previous play_arrow skip_next
00:00 00:00
chevron_left
volume_up
chevron_left
  • play_arrow

    North Derbyshire Radio

World News

Anti nausea drug linked to stroke risk in study

todayMarch 24, 2022 7

Background
share close

Anti-nausea drug linked to stroke risk in study

Research has been published in The BMJ

An anti-nausea drug has been linked to an increased risk of stroke in a new study.

Research published in The BMJ found that drugs known as antidopaminergic antiemetics (ADAs), which are widely used to relieve nausea and vomiting, could lead to an increased risk, especially in the first few days of use.

Academics in France identified 2,600 patients in a French healthcare database who had a stroke between 2012 and 2016 and who had been prescribed one of three ADAs – domperidone, metopimazine, and metoclopramide.

These were compared with almost 22,000 people who had not had a stroke.

After taking account of potentially influential factors, the researchers found that new users of ADAs had a three-fold increased risk of stroke.

The analysis suggested that the risk was higher in the “first days of use”.

“Use of antidopaminergic antiemetics is associated with an increased risk of ischaemic stroke,” the authors wrote.

“The highest risk was observed for metopimazine and metoclopramide.”

Published: 24/03/2022 by Radio NewsHub

Written by: NDR NEWS

Rate it

Previous post

World News

Prosecutions launched over Croydon tram crash

The Office of Rail and Road said it is prosecuting Transport for London, FirstGroup-owned Tram Operations Limited and driver Alfred Dorris Prosecutions have been launched over alleged health and safety failings relating to the Croydon tram crash. The Office of Rail and Road (ORR) said it is prosecuting Transport for London (TfL), FirstGroup-owned Tram Operations Limited (TOL) and driver Alfred Dorris. Seven passengers died and 51 were injured when a […]

todayMarch 24, 2022 7


0%